Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand · Tablet · Updated Nov 11, 2026

Invokamet 50 mg / 500 mg tablet price what pharmacies pay, and what you should

Pharmacies pay$286.94for 30 tablets · $9.56 per tablet
Fair cash price$340.48cost + 15% + $10.50 fee
No change in 4 weeks+0.2% in a yearLast change Oct 21, 2026: pharmacies' invoice prices changed (survey)

Is my price fair?

Check the price you were quoted

Type what the pharmacy asked for invokamet 50 mg / 500 mg tablet and see the markup over what they pay.

How many?
$
Pharmacies payNADAC this week$286.94
Online cost-pluscost + 15% + fees$339.98
Fair cash pricecost + 15% + $10.50 fee$340.48
Your quotetype it above-
Pharmacies pay about $286.94 for 30 tablets. A fair cash price is around $340.48. Type your quote to see your markup.

A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.

Invokamet 50 mg / 500 mg price history

What pharmacies pay for 30 tablets, weekly
$269.51$280.98$292.44$303.91DecFebAprJunAugOct
What pharmacies paid for 30 tablets of invokamet 50 mg / 500 mg tablet over 52 weeks: from $286.37 on Nov 12, 2025 to $286.94 on Nov 11, 2026.
Now
$286.94
52-week low
$286.61
52-week high
$287.05
A year ago
$286.37

Why the price changed

EffectiveBeforeAfterChangeReason
Oct 21, 2026$9.56$9.56No changepharmacies' invoice prices changed (survey)
Sep 23, 2026$9.57$9.56-0.1%pharmacies' invoice prices changed (survey)
Aug 19, 2026$9.55$9.57+0.2%pharmacies' invoice prices changed (survey)
Jul 22, 2026$9.56$9.55-0.1%pharmacies' invoice prices changed (survey)
Jun 17, 2026$9.55$9.56+0.1%pharmacies' invoice prices changed (survey)
Apr 22, 2026$9.56$9.55No changepharmacies' invoice prices changed (survey)
Feb 18, 2026$9.56$9.56No changepharmacies' invoice prices changed (survey)
Dec 17, 2025$9.56$9.56No changepharmacies' invoice prices changed (survey)

Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.

What did you pay for invokamet 50 mg / 500 mg tablet? Share it.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Supply status: shortages & recalls

No shortage reportedChecked Nov 17, 2026
No ongoing recalls1 recall on record, latest Nov 2, 2016

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

Every manufacturer and package code

1 company sell invokamet 50 mg / 500 mg tablet under 1 package code (NDC).

MakerPack sizesPackage codesPer unit
Janssen Pharmaceuticals, Inc.60 tablets50458-540-60 $9.56
All 1 package codes

A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.

Questions to ask your pharmacist

  1. "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
  2. "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
  3. "Do you match other pharmacies or accept discount cards?" Many do, if you ask.

These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.

Other invokamet strengths and forms

Strength and formPer unitPharmacies pay4 weeks52 weeks
50 mg / 1000 mg (24 hr) extended-release tablet Brand$9.69$290.63 / 30 tabletsNo change+1.5%
50 mg / 500 mg (24 hr) extended-release tablet Brand$9.68$290.33 / 30 tabletsNo change+0.1%
150 mg / 1000 mg (24 hr) extended-release tablet Brand$9.52$285.55 / 30 tablets-0.2%-0.3%
150 mg / 500 mg (24 hr) extended-release tablet Brand$9.56$286.88 / 30 tabletsNo change-0.1%
50 mg / 1000 mg tablet Brand$9.54$286.29 / 30 tablets+0.1%+0.1%
150 mg / 1000 mg tablet Brand$9.55$286.51 / 30 tablets-0.3%-0.5%
150 mg / 500 mg tablet Brand$9.60$288.04 / 30 tablets-0.1%+0.6%

Official label & what changed

Last changedAugust 25, 2026
Version32 of 30
EffectiveAug 24, 2026
Read the label

These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014

This drug has a boxed warning

WARNING: LACTIC ACIDOSIS

Post-marketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (> 5 mmol/Liter), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL [see Warnings and Precautions (5.1)].

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic impairment, and mitochondrial diseases [see Warnings and Precautions (5.1)].

Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the full prescribing information [see Dosage and Administration (2.2, 2.3), Contraindications (4), Warnings and Precautions (5.1), Drug Interactions (7), and Use in Specific Populations (8.6, 8.7)].

If metformin-associated lactic acidosis is suspected, immediately discontinue INVOKAMET or INVOKAMET XR and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended [see Warnings and Precautions (5.1)].

WARNING: LACTIC ACIDOSIS

See full prescribing information for complete boxed warning.

Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL. (5.1)

Risk factors include renal impairment, concomitant use of certain drugs, age >65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, hepatic impairment, and mitochondrial diseases. Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information. (5.1)

If lactic acidosis is suspected, discontinue INVOKAMET or INVOKAMET XR and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended. (5.1)

Recent major changes (as listed on the label)

Boxed Warning | 08/2026 |

Dosage and Administration | |

Recommendations Regarding Missed Dose (2.7) | 08/2026 |

Warnings and Precautions | |

Lactic Acidosis (5.1) | |

Genitourinary Infections, including Urosepsis, Pyelonephritis, Necrotizing Fasciitis of the Perineum

(Fournier's Gangrene), and Genital Mycotic Infections (5.5) | 08/2026 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Questions about invokamet 50 mg / 500 mg tablet

How much does invokamet 50 mg / 500 mg tablet cost without insurance?

Pharmacies pay about $286.94 for 30 tablets ($9.56 per tablet) as of November 11, 2026. A fair cash price is about $340.48: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $339.98 including shipping.

Is my price for invokamet 50 mg / 500 mg tablet fair?

Compare it with the fair cash price of $340.48 for 30 tablets. Up to about $425.60 is fair; above $680.96 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.

Is invokamet 50 mg / 500 mg tablet getting more expensive?

Over the last four weeks the price pharmacies pay held steady. Over a year it is about the same. See the 52-week chart.

Who makes invokamet 50 mg / 500 mg tablet?

1 company: Janssen Pharmaceuticals, Inc.. See every package code.

Is invokamet in shortage?

No shortage is reported right now. We check every day.

Has invokamet been recalled?

1 recall on record. Recalls name specific lots - check yours.

What does "pharmacies pay" mean?

It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.

Talk about invokamet 50 mg / 500 mg tablet

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.